In this episode, Oren Gilad, CEO of Aprea Therapeutics, shares insights into targeted cancer therapies, the science behind synthetic lethality, and the company's latest clinical progress. Discover how innovative approaches are changing the paradigm of cancer treatment and what the future holds.Aprea Therapeutics: <a href="https://aprea.com/" rel="noopener noreferrer nofollow">https://aprea.com/</a>Nano Cap Podcast: <a href="https://www.nanocappod.com/" rel="noopener noreferrer nofollow">https://www.nanocappod.com/</a>DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

Syntholene Energy - $SYNTF - Ep:080 - Nano Cap Podcast

On the Nano Cap Podcast, we dive into the unique world of publicly traded companies with a market capitalization under $50 million – the nano caps. These are not just numbers on a stock ticker; they are stories of ambition, struggle, and triumph.

Each episode, I'll sit down with the leaders and visionaries behind these companies. We’ll uncover the challenges they face, the innovations they bring, and the strategies that drive them forward in a competitive market.